(Report) NCD Japan Forum 2013 – The Role of Japan in International NCD control
date : 11/30/2013
As the medical costs to combat NCDs is soaring with an underline issue of aging society, a new strategy is needed for the future that goes beyond tackling and treating individual diseases.
Therefore HGPI cooperate with domestic and international stakeholders including the NCD Alliance, we moved forward with the establishment of NCD Alliance Japan as a forum for sharing and discussing international knowledge on NCDs. (http://ncdjapan.org/en/)
NCD Alliance Japan aims to contribute to the promotion of comprehensive cross-disease measures through discussion with multiple stakeholders involved with each respective disease.
This forum aims to clarify the strength of Japan in NCD control, and discussed how Japan can contribute to the International NCD control.
[Forum Details]
■Date: 2013.11.30 (Sat) 10:00-12:30
■Place: Academy Hills Tower Hall B (6-10-1 Roppongi, Minato-ku, Tokyo)
■Participants: Related ministry officials, embassy officials, medical personnel, healthcare companies, healthcare policy and NCD control specialists, major media, journalists etc.
■Program: ※title omitted
1.Opening Remarks (10:00 – 10:05)
・Kiyoshi Kurokawa(Chairman, HGPI)
2.Session 1: Japan’s strength in NCD that empowers the world(10:10-10:55)
Explore the strength of Japan for international expansion by looking back at the NCD related measures in Japan.
・Tastuya Kondo(Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA))
“International harmonization of regulatory science”
・Shiro Konuma(Director, Global Health Policy Division, the Ministry of Foreign Affairs of Japan / Member, The Global Health Innovative Technology Fund (GHIT Fund))
“The possibility of having an insurance system that allows all citizens to be covered in overseas as in Japan”
・Eriya Kitano (Executive Director, Medical Excellence JAPAN)
“Overseas expansion of medical technology in Japan”
・Risa Nakamura (Program coordinator, United Nations Development Programme in Chad office)(Moderator)
・Toshio Miyata (Executive Director, HGPI / Special Advisor to the Cabinet about Health Care and Research Strategy ) (Moderator)
3.Session 2: To contribute to NCD control at a global level (11:00-11:45)
Introducing the success stories from overseas, understanding current issues and the secret of success
・Yoshiki Sawa (Professor and chief, Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine)
“Overseas expansion of regenerative medicine in Japan”
・Yasuhiro Fujiwara(Director-General, Strategic Planning Bureau, National Cancer Center)
“Overseas expansion of Japan cancer healthcare”
・Masafumi Nogimori (Representative Director and Chairman, Astellas Pharma Inc. / Vice President, Japan Pharmaceutical Manufacturers Association(JPMA))
“The role of the pharmaceutical industry in NCD measures: – the responsibilities of partnership in health and medical care”
・Risa Nakamura (Program coordinator, United Nations Development Programme in Chad office)(Moderator)
・Toshio Miyata (Executive Director, HGPI / Special Advisor to the Cabinet about Health Care and Research Strategy ) (Moderator)
4.Special Remark
・Hidehito Sekino (Director, Office of Medical Devices Policy Health, Policy Bureau, Ministry of Health, Labour and Welfare)
5.Panel Discussion – The role of Japan in International NCD control (11:50-12:20)
Discussion of the role of Japan in International NCD control and how Japan’s experience can be fully utilized base on the discussions in session 1 and 2
・Tastuya Kondo(Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA))
・Shiro Konuma(Director, Global Health Policy Division, the Ministry of Foreign Affairs of Japan / Member, The Global Health Innovative Technology Fund (GHIT Fund))
・Eriya Kitano (Executive Director, Medical Excellence JAPAN)
・Yoshiki Sawa (Professor and chief, Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine)
・Yasuhiro Fujiwara (Director-General, Strategic Planning Bureau, National Cancer Center)
・Masafumi Nogimori (Representative Director and Chairman, Astellas Pharma Inc. / Vice President, Japan Pharmaceutical Manufacturers Association(JPMA))
・Hidehito Sekino (Director, Office of Medical Devices Policy Health, Policy Bureau, Ministry of Health, Labour and Welfare)
・Risa Nakamura (Program coordinator, United Nations Development Programme in Chad office)(Moderator)
・Toshio Miyata (Executive Director, HGPI / Special Advisor to the Cabinet about Health Care and Research Strategy ) (Moderator)
6.Closing Remarks: The effort of NCD Alliance Japan (12:25-12:30)
・Toshio Miyata (Executive Director, HGPI / Special Advisor to the Cabinet about Health Care and Research Strategy ) (Moderator)
About Health and Global Policy Institute:
Since establishment, Health and Global Policy Institute has been working to help citizens shape health policies by generating policy options, and to bring stakeholders together as a non-partisan think-tank, as is stipulated in the mission statement. One of the Institute’s guiding principles is independence, not to be restricted by interests of any organization or political party. The Institute will continue to maintain political neutrality and independence from any organization in conducting its activities.
For more information, please visit at http://www.hgpi.org/en/
About NCD Alliance:
The NCD Alliance is a global partnership formed originally by 4 international federations: the International Diabetes Federation, Union for International Cancer Control, World Heart Federation, and International Union Against Tuberculosis and Lung Disease. Uniting a network of over 2,000 civil society organizations in more than 170 countries, the NCD Alliance’s mission is to combat the NCD epidemic by putting health at the center of all policies.
For more information, please visit at http://ncdalliance.org/
Registration deadline: 2013-11-29
Exhibition date:2013-11-30
Top Research & Recommendations Posts
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Policy Recommendations] Dementia Prevention Initiatives for Achieving a Dementia-Friendly and Inclusive Society (March 26, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Three Necessary Perspectives for Formulating the Basic Plan for the Promotion of Policies on Dementia: Creating a Society That is Inclusive for All People at All Times (April 1, 2024)
- [Policy Recommendations] Establishing an integrated care system for pain from the perspectives of people with lived experience (March 29, 2024)
Featured Posts
-
2024-04-02
[Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
-
2024-04-08
[Event Report] HGPI Participates in the Connecting Climate Minds Global Event (March 19-21, 2024)
-
2024-04-08
[Registration Open] The 124th HGPI Seminar “Reconsidering Infectious Disease Control Strategies Centering on Vaccination and Immunization – From the Experiences of the COVID-19 Pandemic and a Life Course Approach” (April 26, 2024)
-
2024-04-10
[Research Report] “International comparison of dementia policies, research study on information dissemination.” (April 10, 2024)
-
2024-04-11
[Research Paper] “Exploring the Potential of Industry-Academia-Civil Collaboration for Sustainability in the Healthcare Sector” Published in Journal Society for Environmental Economics and Policy Studies (March 31, 2024)